Today's Daily Dose brings you news about Apellis Pharma's PEGASUS study results; Advaxis' progress with ADXS-504 in prostate cancer; CEL-SCI Corp's stock offering and Tyme's strategic collaboration with Eagle Pharma.
from RTT - Biotech https://ift.tt/37JsHbH
via IFTTT
No comments:
Post a Comment